Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIRZEPATIDE for Hypercholesterolaemia: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 10 adverse event reports in the FDA FAERS database where TIRZEPATIDE was used for Hypercholesterolaemia.

Most Reported Side Effects for TIRZEPATIDE

Side Effect Reports % Deaths Hosp.
Incorrect dose administered 23,301 23.3% 1 67
Injection site pain 10,989 11.0% 0 33
Nausea 10,018 10.0% 20 867
Off label use 7,007 7.0% 21 425
Extra dose administered 6,774 6.8% 1 32
Diarrhoea 5,463 5.5% 22 725
Vomiting 4,635 4.6% 27 1,004
Injection site haemorrhage 4,389 4.4% 0 12
Accidental underdose 3,897 3.9% 0 7
Injection site erythema 3,844 3.9% 0 14
Constipation 3,417 3.4% 6 341
Product dose omission issue 3,211 3.2% 0 47
Injection site bruising 2,665 2.7% 0 14
Drug ineffective 2,648 2.7% 0 44
Fatigue 2,301 2.3% 5 123

Other Indications for TIRZEPATIDE

Product used for unknown indication (56,075) Weight control (17,354) Type 2 diabetes mellitus (14,571) Diabetes mellitus (5,209) Weight decreased (2,625) Glucose tolerance impaired (2,452) Obesity (700) Sleep apnoea syndrome (654) Insulin resistance (572) Glycosylated haemoglobin increased (564)

Other Drugs Used for Hypercholesterolaemia

EVOLOCUMAB (23,505) ATORVASTATIN (5,615) ALIROCUMAB (4,924) SIMVASTATIN (3,010) ROSUVASTATIN (2,690) EZETIMIBE (1,589) PRAVASTATIN (764) INCLISIRAN (486) FENOFIBRATE (286) FLUVASTATIN (264)

Related Pages

TIRZEPATIDE Full Profile All Hypercholesterolaemia Drugs TIRZEPATIDE Demographics TIRZEPATIDE Timeline